All lobbying filings

ML Strategies, LLC

ML Strategies, LLC filed a Q2 report for Johnson & Johnson Services, Inc. on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Johnson & Johnson Services, Inc. · â€‹Medical device manufacturer

As filed: ML STRATEGIES, LLC for JOHNSON & JOHNSON SERVICES, INC.

All filings by ML Strategies, LLC · Everything Johnson & Johnson Services, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to cardiovascular health; H.R.5343 / S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025; issues related to Heart Recovery Awareness Day and H. Res. 1301, designating February 20th Heart Recovery Awareness Day

Bills named in this filing 3

H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
H. Res. 1301
Expressing support for the inaugural Heart Recovery Awareness Day on February 20, 2025.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.